| Financial Year |
March 31 2023 |
| Monetary Funds |
165,611,626.66 |
| Held-for-trading Financial Assets |
1,700,828.00 |
| Notes Receivable |
72,429,694.89 |
| Accounts Receivable |
240,760,750.55 |
| Advances to Suppliers |
9,459,707.79 |
| Other Receivables |
12,733,492.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
157,766,471.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
100,549,626.74 |
| Total Current Assets |
761,012,198.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,800,000.00 |
| Long-term Equity Investment |
28,357,054.43 |
| Investment Properties |
27,380,989.44 |
| Fixed Assetes |
1,540,008,705.28 |
| Under-construction Projects |
284,182,885.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,438,820.74 |
| R&D expenses |
-- |
| Goodwill |
1,746,589.64 |
| Long-Term Deferred and Prepaid Expenses |
547,553.19 |
| Deferred Income Tax Assets |
6,677,394.53 |
| Other Non-Current Assets |
47,205,089.34 |
| Sub-Total of Non-Current Assets |
2,050,345,082.15 |
| Total Assets |
2,811,357,280.79 |
| Short-Term Loans |
143,270,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,374,862.30 |
| Accounts Payable |
131,775,929.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,302,455.52 |
| Taxes Payable |
15,467,320.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
258,198,639.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
107,302,840.91 |
| Other Current Liabilities |
92,179,508.18 |
| Sub-Total of Current Liabilities |
828,756,562.45 |
| Long-term Loans |
840,555,488.04 |
| Bonds Payable |
193,760,790.44 |
| Long-Term Accounts Payable |
52,063,486.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,115,183,313.68 |
| Total Liabilities |
1,943,939,876.13 |
| Paid-In Capital(Or Share Stock) |
106,089,713.00 |
| Capital Surplus |
499,084,219.37 |
| Surplus Reserve |
26,392,782.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
174,929,351.38 |
| Minority Stockholder's Interest |
20,341,768.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
847,075,636.07 |
| Owner's Equity（Stockholder's Equity） |
867,417,404.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,811,357,280.79 |
